Unknown

Dataset Information

0

Human and mouse colon cancer utilizes CD95 signaling for local growth and metastatic spread to liver.


ABSTRACT: Analysis of clinical colon cancer specimens show alterations in the CD95 (Fas Ag/Fas L) pathway as tumors progress from local to metastatic disease, suggesting that this pathway may play a role in invasive behavior of colon cancer. However, direct causality between these alterations and clinical disease progression has not been shown.Surgically resected metastatic colon cancer samples were evaluated for Fas Ag/L and apoptosis. Alterations in the Fas-signaling pathway found in human samples were recreated through a series of staged transfection experiments in the MC38 mouse colon cancer cell line and the effects on growth tested in vitro and in vivo.Expression of FLICE-like inhibitory protein confers apoptosis resistance, increasing the incidence of primary tumors through a survival advantage by avoiding apoptosis and inducing Fas-mediated proliferation. Coexpression of Fas L enables colon cancer cells to metastasize to the liver from local tumors as well as from intravenous injection of cells. MC38-FasL/FLICE-like inhibitory protein colon cancer cells induce apoptosis in hepatocytes via activation of type II Fas Ag signaling, thus creating a niche conducive to tumor growth and fueling their own growth via Fas proliferative signaling.Alterations in the Fas Ag pathway which inhibit apoptosis and increase Fas-mediated proliferation directly increase local colon cancer growth, and enhance metastasis to the liver. Delineating points in the pathway responsible for growth and metastasis will offer targets that may be exploited for therapy.

SUBMITTER: Li H 

PROVIDER: S-EPMC2763556 | biostudies-other | 2009 Sep

REPOSITORIES: biostudies-other

altmetric image

Publications

Human and mouse colon cancer utilizes CD95 signaling for local growth and metastatic spread to liver.

Li Hanchen H   Fan Xueli X   Stoicov Calin C   Liu Jian Hua JH   Zubair Sharif S   Tsai Elena E   Ste Marie Ronald R   Wang Timothy C TC   Lyle Stephen S   Kurt-Jones Evelyn E   Houghton Jeanmarie J  

Gastroenterology 20090612 3


<h4>Background & aims</h4>Analysis of clinical colon cancer specimens show alterations in the CD95 (Fas Ag/Fas L) pathway as tumors progress from local to metastatic disease, suggesting that this pathway may play a role in invasive behavior of colon cancer. However, direct causality between these alterations and clinical disease progression has not been shown.<h4>Methods</h4>Surgically resected metastatic colon cancer samples were evaluated for Fas Ag/L and apoptosis. Alterations in the Fas-sign  ...[more]

Similar Datasets

| S-EPMC4572867 | biostudies-other
| S-EPMC3561803 | biostudies-literature
| S-EPMC10930793 | biostudies-literature
| S-EPMC5581028 | biostudies-literature
| S-EPMC7394901 | biostudies-literature
| S-EPMC7214685 | biostudies-literature
| S-EPMC2879093 | biostudies-other
| S-EPMC4859731 | biostudies-literature
| S-EPMC4438141 | biostudies-literature
| S-EPMC1409734 | biostudies-literature